Nagisa Hanawa

752 citations

37 papers · 507 indexed · h-index 15

Endocrinology, Diabetes and Metabolism top 5%
- Diet, Metabolism, and Disease 9
- Diabetes, Cardiovascular Risks, and Lipoproteins 6
Hepatology top 10%
- Liver Disease and Transplantation 6
Nephrology top 10%
Epidemiology top 10%
- Liver Disease Diagnosis and Treatment 22
Pathology and Forensic Medicine
- Alcohol Consumption and Health Effects 10
Surgery
- Lipoproteins and Cardiovascular Health 5
- Pancreatitis Pathology and Treatment 3
Radiology, Nuclear Medicine and Imaging
- Cardiac Imaging and Diagnostics 3

Co-authors: Marenao Tanaka Masato Furuhashi Hirofumi Ohnishi Kazuma Mori Yukimura Higashiura Tetsuji Miura Norihito Moniwa Masayuki Koyama
Cited by: Endocrinology, Diabetes and Metabolism Hepatology Nephrology
Journals: SHILAP Revista de lepidopterología (2 papers)Diabetes (1 paper)Scientific Reports (2 papers)
Partner nations: Japan Taiwan United States

In The Last Decade

Nagisa Hanawa

34 papers receiving 502 citations

Peers

Countries citing papers authored by Nagisa Hanawa

Since Specialization

Citations

This map shows the geographic impact of Nagisa Hanawa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nagisa Hanawa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nagisa Hanawa more than expected).

Fields of papers citing papers by Nagisa Hanawa

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nagisa Hanawa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nagisa Hanawa. The network helps show where Nagisa Hanawa may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Nagisa Hanawa, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Nagisa Hanawa Line = papers co-authored together Nagisa Hanawa links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	High Level of Estimated Small Dense Low-Density Lipoprotein Cholesterol as an Independent Risk Factor for the Development of Ischemic Heart Disease Regardless of Low-Density Lipoprotein Cholesterol Level　― A 10-Year Cohort Study ― Circulation Journal ·Keisuke Endo,Marenao Tanaka,Tatsuya Sato,Masafumi Inyaku,Kei Nakata,Wataru Kawaharata,Hiroki Aida,Itaru Hosaka,Yukinori Akiyama,Nagisa Hanawa,Masato Furuhashi	2025	2
2	Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) Is an Independent Risk Factor for the Development of Ischemic Heart Disease　― A 10-Year Cohort Study ― Circulation Reports ·Toshifumi Ogawa,Tatsuya Sato,Marenao Tanaka,Yukinori Akiyama,Kei Nakata,Hidemichi Kouzu,Kazuma Mori,Hiroki Aida,Wataru Kawaharata,Itaru Hosaka,Toru Suzuki,Nagisa Hanawa,Masato Furuhashi	2025	2
3	Elevated level of estimated small dense LDL cholesterol is independently associated with the development of hypertension, regardless of LDL cholesterol level Hypertension Research ·Hiroki Aida,Marenao Tanaka,Tatsuya Sato,Wataru Kawaharata,Rie Matsumori,Itaru Hosaka,Yukinori Akiyama,Kei Nakata,Hidemichi Kouzu,Nagisa Hanawa,(unknown)	2025	0
4	Deciphering metabolic dysfunction‐associated steatotic liver disease: insights from predictive modeling and clustering analysis Journal of Gastroenterology and Hepatology ·Kazuma Mori,Yukinori Akiyama,Marenao Tanaka,Tatsuya Sato,Keisuke Endo,Itaru Hosaka,Nagisa Hanawa,Naoya Sakamoto,Masato Furuhashi	2024	12
5	Metabolic dysfunction‐associated steatotic liver disease (SLD) and alcohol‐associated liver disease, but not SLD without metabolic dysfunction, are independently associated with new onset of chronic kidney disease during a 10‐year follow‐up period Hepatology Research ·Kazuma Mori,Marenao Tanaka,Tatsuya Sato,Yukinori Akiyama,Keisuke Endo,Toshifumi Ogawa,Toru Suzuki,Hiroki Aida,Wataru Kawaharata,Kei Nakata,Itaru Hosaka,Araya Umetsu,Nagisa Hanawa,Masato Furuhashi	2024	14
6	Predictive modeling for the development of diabetes mellitus using key factors in various machine learning approaches SHILAP Revista de lepidopterología ·Marenao Tanaka,Yukinori Akiyama,Kazuma Mori,Itaru Hosaka,Kenichi Kato,Keisuke Endo,Toshifumi Ogawa,Tatsuya Sato,Toru Suzuki,Toshiyuki Yano,Hirofumi Ohnishi,Nagisa Hanawa,Masato Furuhashi	2023	10
7	Calculated Small Dense Low-Density Lipoprotein Cholesterol Level is A Predominant Predictor for New Onset of Ischemic Heart Disease Journal of Atherosclerosis and Thrombosis ·Masafumi Inyaku,Marenao Tanaka,Tatsuya Sato,Keisuke Endo,Kazuma Mori,Itaru Hosaka,Takuma Mikami,Araya Umetsu,Hirofumi Ohnishi,Yukinori Akiyama,Nagisa Hanawa,Masato Furuhashi	2023	9
8	An increase in calculated small dense low-density lipoprotein cholesterol predicts new onset of hypertension in a Japanese cohort Hypertension Research ·Marenao Tanaka,Tatsuya Sato,Keisuke Endo,Masafumi Inyaku,Kazuma Mori,Itaru Hosaka,Takuma Mikami,Yukinori Akiyama,Hirofumi Ohnishi,Nagisa Hanawa,Masato Furuhashi	2023	11
9	Coexistence of Metabolic Dysfunction‐Associated Fatty Liver Disease and Chronic Kidney Disease Is a More Potent Risk Factor for Ischemic Heart Disease Journal of the American Heart Association ·Daisuke Miyamori,Marenao Tanaka,Tatsuya Sato,Keisuke Endo,Kazuma Mori,Takuma Mikami,Itaru Hosaka,Nagisa Hanawa,Hirofumi Ohnishi,Masato Furuhashi	2023	20
10	A high level of thyroid-stimulating hormone is a risk factor for the development of chronic kidney disease in men: a 10-year cohort study Hypertension Research ·Keisuke Endo,Marenao Tanaka,Tatsuya Sato,Kazuma Mori,Itaru Hosaka,Takuma Mikami,Araya Umetsu,Yukinori Akiyama,Hirofumi Ohnishi,Nagisa Hanawa,Masato Furuhashi	2023	3
11	Metabolic dysfunction-associated fatty liver disease is associated with an increase in systolic blood pressure over time: linear mixed-effects model analyses Hypertension Research ·Kazuma Mori,Marenao Tanaka,Itaru Hosaka,Takuma Mikami,Keisuke Endo,Nagisa Hanawa,Hirofumi Ohnishi,Masato Furuhashi	2023	14
12	Fatty liver index is independently associated with deterioration of renal function during a 10-year period in healthy subjects Scientific Reports ·Satoko Takahashi,Marenao Tanaka,Masato Furuhashi,Norihito Moniwa,Masayuki Koyama,Yukimura Higashiura,Arata Osanami,Yufu Gocho,Hirofumi Ohnishi,Keita Numata,Takashi Hisasue,Nagisa Hanawa,Tetsuji Miura	2021	28
13	High level of fatty liver index predicts new onset of diabetes mellitus during a 10-year period in healthy subjects Scientific Reports ·Yukimura Higashiura,Masato Furuhashi,Marenao Tanaka,Satoko Takahashi,Masayuki Koyama,Hirofumi Ohnishi,Keita Numata,Takashi Hisasue,Nagisa Hanawa,Norihito Moniwa,Kazufumi Tsuchihashi,Tetsuji Miura	2021	27
14	A Deep Learning Architecture for Vascular Area Measurement in Fundus Images SHILAP Revista de lepidopterología ·Kanae Fukutsu,Michiyuki Saito,Kousuke Noda,Miyuki Murata,Satoru Kase,Ryosuke Shiba,Naoki Isogai,Yoshikazu Asano,Nagisa Hanawa,Mitsuru Dohke,Manabu Kase,Susumu Ishida	2021	14
15	Serum uric acid level is associated with an increase in systolic blood pressure over time in female subjects: Linear mixed-effects model analyses Hypertension Research ·Kazuma Mori,Masato Furuhashi,Marenao Tanaka,Yukimura Higashiura,Masayuki Koyama,Nagisa Hanawa,Hirofumi Ohnishi	2021	10
16	U-shaped relationship between serum uric acid level and decline in renal function during a 10-year period in female subjects: BOREAS-CKD2 Hypertension Research ·Kazuma Mori,Masato Furuhashi,Marenao Tanaka,Keita Numata,Takashi Hisasue,Nagisa Hanawa,Masayuki Koyama,Arata Osanami,Yukimura Higashiura,Masafumi Inyaku,Megumi Matsumoto,Norihito Moniwa,Hirofumi Ohnishi,Tetsuji Miura	2020	33
17	Inverse Association Between Fatty Liver at Baseline Ultrasonography and Remission of Type 2 Diabetes Over a 2-Year Follow-up Period Clinical Gastroenterology and Hepatology ·Hajime Yamazaki,Jui Wang,Shinichi Tauchi,Mitsuru Dohke,Nagisa Hanawa,Akio Katanuma,Yoshifumi Saisho,Tsukasa Kamitani,Shunichi Fukuhara,Yosuke Yamamoto	2020	7
18	Longitudinal association of fatty pancreas with the incidence of type-2 diabetes in lean individuals: a 6-year computed tomography-based cohort study Journal of Gastroenterology ·Hajime Yamazaki,Shinichi Tauchi,Jui Wang,Mitsuru Dohke,Nagisa Hanawa,Yoshihisa Kodama,Akio Katanuma,Yoshifumi Saisho,Tsukasa Kamitani,Shunichi Fukuhara,Yosuke Yamamoto	2020	30
19	Insulin Resistance is Associated with Longitudinal Changes of Cardiac Repolarization Heterogeneity in Apparently Healthy Subjects Cardiology and Therapy ·Tamaki Matsumoto,Hirofumi Ohnishi,Tatsuya Sato,Takayuki Miki,Hiroshi Akasaka,Nagisa Hanawa,Masayuki Koyama,Shigeyuki Saitoh,Tetsuji Miura	2019	10
20	The impact of elevation of serum uric acid level on the natural history of glomerular filtration rate (GFR) and its sex difference Nephrology Dialysis Transplantation ·Hiroshi Akasaka,Hideaki Yoshida,Hideki Takizawa,Nagisa Hanawa,Toshiyuki Tobisawa,Marenao Tanaka,Norihito Moniwa,Nobuhiko Togashi,Tomohisa Yamashita,Setsuko Kuroda,Nobuyuki Ura,Tetsuji Miura,(unknown)	2014	30

About Nagisa Hanawa

Nagisa Hanawa is a scholar working on Endocrinology, Diabetes and Metabolism, Hepatology and Nephrology, having authored 37 papers that have together received 507 indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (22 papers), Alcohol Consumption and Health Effects (10 papers), Diet, Metabolism, and Disease (9 papers), Liver Disease and Transplantation (6 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (6 papers), Lipoproteins and Cardiovascular Health (5 papers), Cardiac Imaging and Diagnostics (3 papers) and Pancreatitis Pathology and Treatment (3 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (211 citations), Hepatology (92 citations) and Nephrology (78 citations). Nagisa Hanawa has collaborated with scholars based in Japan, Taiwan and United States. Frequent co-authors include Marenao Tanaka, Masato Furuhashi, Hirofumi Ohnishi, Kazuma Mori, Yukimura Higashiura, Tetsuji Miura, Norihito Moniwa, Masayuki Koyama, Satoko Takahashi and Mitsuru Dohke. Their work appears in journals such as SHILAP Revista de lepidopterología, Diabetes and Scientific Reports.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact